Skip to main content
. 2020 May 18;16(2):e1085. doi: 10.1002/cl2.1085
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: “.participants were randomised by the trial statistician (MS) into two groups”
Comment: Insufficient information to permit judgement
Allocation concealment (selection bias) Unclear risk Quote: “.participants were randomised by the trial statistician (MS) into two groups”
Comment: Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) Low risk Quote: “local pharmacist prepared tablets which were identical in number, colour, size and texture to the ergocalciferol, but contained only sucrose.”
Comment: Adequately done
Blinding of outcome assessment (detection bias) Low risk Quote: “All the primary investigators of the study were totally blinded to the treatment regimen.”
Comment: Adequately done.
Incomplete outcome data (attrition bias) Low risk Comment:
Group 1: No loss to follow‐up.
Group 2: 1/50 loss to follow‐up.
Selective reporting (reporting bias) Unclear risk Comment: Trial registration not reported. Outcomes specified in the methodology section were reported
Other bias Low risk Comment: No other biases detected.